PERtussIS COrrelates of Protection Europe
PERISCOPE aims to accelerate the development of improved vaccines against Bordetella pertussis (whooping cough) and/or vaccination strategies that will be used to control B. pertussis in humans. PERISCOPE will develop novel functional antibody and cellular assays and employs cutting-edge methods to characterise innate immune responses and cell-mediated systemic and mucosal immunity.
- Dimitri DiavatopoulosRadboud University Medical CenterPhone: +31 24 3666 336
- Horizon 2020 & sub-programmes
- 78 months (March 2016 - August 2022)
- Project funding
- € 28,000,000.00
- Project partners